Why the study?
Patients with ADHF are usually admitted to hospital, but interest in outpatient IV diuretic therapy is growing and the safety and effectiveness of outpatient-based management have not been established.
Does outpatient-based management reduce 30-day mortality and hospitalization compared to inpatient management in patients with acutely decompensated heart failure?
Does outpatient-based management reduce 30-day mortality and hospitalization compared to inpatient management in patients with acutely decompensated heart failure?
Answers are grounded in this paper and cite their sources.
Outpatient management of acutely decompensated heart failure is associated with lower 30-day mortality and hospitalization in observational studies, but this benefit is not confirmed in small RCTs, highlighting the need for a large randomized trial.
Patients with acutely decompensated heart failure (ADHF) are usually admitted to hospital for management. There is growing interest in delivering intravenous (IV) diuretic therapy at home, in the community or at hospital day-care units; the safety and effectiveness of outpatient-based management (OPM) for ADHF has not been established. We conducted a systematic literature review and meta-analysis to investigate the short-term safety and effectiveness of OPM compared with inpatient management (IPM) of ADHF. Pre-specified endpoints were 30 day mortality and 30 day hospitalization. The meta-analysis was conducted using RevMan 5.4 software. Twenty-nine studies of OPM were identified, including 7683 patients. Only five studies directly compared OPM (n = 1303) with IPM (n = 2047), including three observational studies, and two randomized controlled trials (RCTs). The other 24 studies only stated OPM outcomes. For the five studies comparing IPM versus OPM, patients were generally aged >75 years and of similar age for each strategy, with a similar proportion of men (56%). In a study-level, aggregate analysis, 30 day all-cause mortality was 9.3% (121/1303) for OPM, compared with 15.6% (320/2047) for IPM [OR 0.29 (95% CI 0.09, 0.93) P = 0.04]. Four studies reported 30 day all-cause hospitalization; 22.0% for IPM versus 16.8% for OPM [OR 0.73 (95% CI 0.61, 0.89), P = 0.001]. In the two RCTs, we found no difference in 30 day mortality or hospitalization. In observational studies, OPM of ADHF is associated with lower 30 day hospitalization and lower 30 day mortality; such differences were not observed in two small, single-centre RCTs. A substantial, multicentre RCT is required to confirm the safety and effectiveness of OPM for ADHF.
No takes yet. Share an insight, caveat, or question.
Bahar et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: